6533b7d9fe1ef96bd126c1cc
RESEARCH PRODUCT
Nitric oxide-active compounds modulate the intensity of glutamate-evoked responses in the globus pallidus of the rat
Fabio CarlettiGiuseppe FerraroPierangelo SardoValerio RizzoLonobile GSimonetta Frisciasubject
MaleNOS inhibitorGlutamic AcidNitric oxide - Microiontophoresis - ElectrophysiologyBiologyPharmacologyGlobus PallidusNitric OxideSettore BIO/09 - FisiologiaGeneral Biochemistry Genetics and Molecular BiologyNitric oxidechemistry.chemical_compoundGlutamatergicNitric oxide; Basal ganglia; Single unit electrophysiology; MicroiontophoresisBasal gangliaSingle unit electrophysiologyAnimalsNitric Oxide DonorsRats WistarGeneral Pharmacology Toxicology and PharmaceuticsEvoked PotentialsNeuronsMicroiontophoresisIontophoresisGlutamate receptorExcitatory Postsynaptic PotentialsGeneral MedicineIontophoresisRatsNG-Nitroarginine Methyl EsterGlobus pallidusBiochemistrychemistryBasal gangliaExcitatory postsynaptic potentialNitric Oxide SynthaseMicroelectrodesdescription
Abstract Aim The effects of local applied NO-active compounds on glutamate (GLU)-evoked responses were investigated in globus pallidus (GP) neurons. Main methods Extracellularly recorded single units from anesthetized rats were treated with GLU before and during the microiontophoretic application of S-nitrosoglutathione (SNOG), a NO donor, and Nω-nitro- l -arginine methyl ester (L-NAME), a NOS inhibitor. Key findings Most GP cells were excited by SNOG whereas administration of L-NAME induced decrease of GP neurons activity. Nearly all neurons responding to SNOG and/or L-NAME showed significant modulation of their excitatory responses to the administration of iontophoretic GLU. In these cells, the changes induced by NO-active drugs in the magnitude of GLU-evoked responses were used as indicators of NO modulation. In fact, when a NO-active drug was co-iontophoresed with GLU, significant changes in GLU-induced responses were observed: generally, increased magnitudes of GLU-evoked responses were observed during SNOG ejection, whereas the administration of L-NAME decreased responses to GLU. Significance The results suggest that the NO-active drugs modulate the response of GP neurons to glutamatergic transmission. Nitrergic modulation of glutamatergic transmission could play an important role in the control of GP bioelectric activity, considered a fundamental key in the BG function.
year | journal | country | edition | language |
---|---|---|---|---|
2011-01-01 | Life Sciences |